Truist Financial heads into the back half of July with short sellers quietly covering and analysts sharply divided after a Q2 print that pleased no one completely.
The clearest development this week is the sustained unwinding of short positions. Short interest has fallen roughly 14% over the past month to 2.2% of the free float — a level that was above 3% as recently as early July. The retreat is orderly rather than panicked: borrow costs remain negligible at 0.51%, and availability is extraordinarily loose at over 3,300% of current short interest, meaning the lending pool is essentially unlimited relative to demand. This is not a squeeze situation. Short sellers are simply stepping back from a bank they had been pressing harder into the first half. The ORTEX short score has drifted lower alongside, settling near 34 from a reading above 35 earlier this month — consistent with a stock where bearish conviction is fading rather than building.
Options tell a slightly more cautious story, though not an alarming one. The put/call ratio is running at 0.76, modestly above its 20-day average of 0.73 and about 0.8 standard deviations above that mean. That puts it well below the year's defensive extreme of 1.53 set earlier in the year. Options traders are neither aggressive bulls nor rattled bears here — positioning looks broadly neutral with a slight tilt toward hedging.
The Street moved sharply on the Q2 results and the picture that emerged is mixed at best. JP Morgan's Vivek Juneja downgraded to Underweight on July 20 and raised his target only modestly to $54 this week — a signal that even after trimming expectations, the firm remains cautious. BofA and UBS both stepped off Buy ratings earlier in the month, moving to Neutral. At the same time, Stephens and Evercore trimmed targets from $59 and $57 to $57 and $56 respectively while keeping positive ratings, suggesting they still see upside from the current $52.99 price but want to see cleaner execution. The mean analyst target sits at $54.92, implying roughly 4% upside — modest enough that the bull case depends more on delivery than on re-rating. Valuation is undemanding: the P/E runs near 11x and price-to-book is just above 1.0, consistent with a bank priced for modest growth rather than a premium franchise.
The earnings history is worth noting. The July 17 Q2 report produced a 4.2% one-day decline and a further 2.8% drift lower over the following five sessions — a pattern that also appeared after the April print, which saw a 1.1% day-one drop extend to a 2.5% five-day loss. Bears point to persistent pressure on net interest income and a wholesale banking segment under strain. Bulls counter with a strong deposit franchise, a reasonable dividend score ranking in the 74th percentile, and fee income that has consistently beaten expectations.
Among closest peers, RF and MTB both gained around 1.5-1.7% on the day, broadly in line with TFC's 1.7% session. HBAN is the notable outlier, down nearly 5% on the week against TFC's 3.1% gain — a divergence worth monitoring as the regional banking cohort digests its own round of Q2 results.
The next scheduled earnings date is October 16. Between now and then, the question is whether the fee income momentum that drove the Q2 beat can offset the continued NII headwinds that have kept analyst targets clustered just above the current price rather than well above it.
See the live data behind this article on ORTEX.
Open TFC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
